Yunovia receives South Korea MFDS approval for Phase I trial of GLP-1 agonist
The company plans to develop ID110521156 as an orally administrable drug.
Approvals
EC conditionally approves Pfizer’s haemophilia B gene therapy
InnoCare receives clearance for leukaemia/lymphoma trial in China
FDA grants IND clearance for OKYO Pharma’s NCP treatment trial
Neurotech to begin Phase I/II trial of NTI164 for cerebral palsy
Kyverna Therapeutics given FDA approval for KYV-101 trial
Antengene gets FDA approval for Phase I trial of cancer drug
Phio Pharmaceuticals receives FDA IND clearance for PH-762 trial
